Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W W Lamph

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
British Journal of Cancer|March 26, 2008
The rexinoid, bexarotene, prevents the development of premalignant lesions in MMTV-erbB2 miceY Li, Y Zhang, J Hill, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 25, 2000
Efficacy of LGD1069 (Targretin), a retinoid X receptor-selective ligand, for treatment of uterine leiomyomaS D Gamage, E D Bischoff, K D Burroughs, et al.
Journal of Medicinal Chemistry|July 5, 1996
Discovery of novel retinoic acid receptor agonists having potent antiproliferative activity in cervical cancer cellsL Zhang, A M Nadzan, R A Heyman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1985
Phenotypic variation in clonal Abelson virus lymphoma cellsP L Green, W W Lamph, J Dudley, et al.
Cancer Research|January 1, 1997
A novel retinoic acid receptor-selective retinoid, ALRT1550, has potent antitumor activity against human oral squamous carcinoma xenografts in nude miceD R Shalinsky, E D Bischoff, W W Lamph, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1996
Enhanced antitumor efficacy of cisplatin in combination with ALRT1057 (9-cis retinoic acid) in human oral squamous carcinoma xenografts in nude miceD R Shalinsky, E D Bischoff, M L Gregory, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2000
Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cellsS Y Sun, P Yue, L Mao, et al.
Cell|June 2, 1995
Identification of a nuclear receptor that is activated by farnesol metabolitesB M Forman, E Goode, J Chen, et al.
Cancer Research|July 15, 1995
Retinoid-induced suppression of squamous cell differentiation in human oral squamous cell carcinoma xenografts (line 1483) in athymic nude miceD R Shalinsky, E D Bischoff, M L Gregory, et al.
The Journal of Urology|June 1, 1993
Platelet derived growth factor (PDGF), androgens and inflammation: possible etiologic factors in the development of prostatic hyperplasiaP E Gleason, J A Jones, J S Regan, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
British Journal of Cancer|March 26, 2008
The rexinoid, bexarotene, prevents the development of premalignant lesions in MMTV-erbB2 miceY Li, Y Zhang, J Hill, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 25, 2000
Efficacy of LGD1069 (Targretin), a retinoid X receptor-selective ligand, for treatment of uterine leiomyomaS D Gamage, E D Bischoff, K D Burroughs, et al.
Journal of Medicinal Chemistry|July 5, 1996
Discovery of novel retinoic acid receptor agonists having potent antiproliferative activity in cervical cancer cellsL Zhang, A M Nadzan, R A Heyman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1985
Phenotypic variation in clonal Abelson virus lymphoma cellsP L Green, W W Lamph, J Dudley, et al.
Cancer Research|January 1, 1997
A novel retinoic acid receptor-selective retinoid, ALRT1550, has potent antitumor activity against human oral squamous carcinoma xenografts in nude miceD R Shalinsky, E D Bischoff, W W Lamph, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1996
Enhanced antitumor efficacy of cisplatin in combination with ALRT1057 (9-cis retinoic acid) in human oral squamous carcinoma xenografts in nude miceD R Shalinsky, E D Bischoff, M L Gregory, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2000
Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cellsS Y Sun, P Yue, L Mao, et al.
Cell|June 2, 1995
Identification of a nuclear receptor that is activated by farnesol metabolitesB M Forman, E Goode, J Chen, et al.
Cancer Research|July 15, 1995
Retinoid-induced suppression of squamous cell differentiation in human oral squamous cell carcinoma xenografts (line 1483) in athymic nude miceD R Shalinsky, E D Bischoff, M L Gregory, et al.
The Journal of Urology|June 1, 1993
Platelet derived growth factor (PDGF), androgens and inflammation: possible etiologic factors in the development of prostatic hyperplasiaP E Gleason, J A Jones, J S Regan, et al.
Pageof 4